About the journal
HemaSphere is an open-access journal published by Wiley in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,880 USD. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2572-9241
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,880 USD
- Articles in DOAJ
- 6912
- Declared review time
- 7 weeks
- Declared peer-review model
- double_blind
- Official website
- https://onlinelibrary.wiley.com/journal/25729241
Index listings
- DOAJ · 2019-06-21
- Indexing
- DOAJ
- APC
- 2,880 USD
- Declared review time (DOAJ)
- 7 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
6912
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
7weeks
Works in OpenAlex
9387
Last recorded publication year
2026
h-index
52
i10-index
453
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2019-06-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 84%
- ORCID iDs in current deposits
- 81%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101740619
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
Show all subjects (50)
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- CAR-T cell therapy research
- CAR-T cell therapy research
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Protein Degradation and Inhibitors
- Blood groups and transfusion
- Protein Degradation and Inhibitors
- Blood groups and transfusion
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Bone and Joint Diseases
- Bone and Joint Diseases
Keywords (DOAJ)
- haematology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ